Skip to main content
Premium Trial:

Request an Annual Quote

Wendell Wierenga, Daniel Gold, Craig Venter, Matthew Trunnell, Dennis Bittner


Ciphergen has appointed Wendell Wierenga, CEO of Syrrx, to its board of directors. Wierenga joined Syrrx as CEO in September 2000, and in previous positions has served as a senior vice president for worldwide pharmaceutical sciences, technology, and development at Pfizer, and as senior vice president of the Parke-Davis Pharmaceutical Research division of Warner-Lambert.

Daniel Gold has joined Human Genome Sciences as senior vice president for process development, the company said last week. In his new position, Gold will be responsible for overseeing the development of manufacturing processes for the production of therapeutic proteins and antibody drugs. In his most recent position, Gold served as vice president for process development and chief scientific officer of Diosynth-RTP, a contract biopharmaceutical process development and manufacturing division of Akzo Nobel. He will report to Craig Rosen, HGS' executive vice president for research and development.

Woburn, Mass.-based U.S. Genomics has appointed Craig Venter to its board of directors and named him as a scientific advisor, the company said last week. This is Venter's first such job in a private-sector setting since leaving Celera Genomics in January.

Matthew Trunnell has joined GeneData of South San Francisco as head of technology for the company’s West Coast office. Dennis Bittner has also joined the company as director of marketing.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.